PL4299063T3 - Kapsułki doustne zawierające tabletki atorwastatyny wykazujące odpowiedni profil rozpuszczania i biodostępność - Google Patents
Kapsułki doustne zawierające tabletki atorwastatyny wykazujące odpowiedni profil rozpuszczania i biodostępnośćInfo
- Publication number
- PL4299063T3 PL4299063T3 PL22382623.1T PL22382623T PL4299063T3 PL 4299063 T3 PL4299063 T3 PL 4299063T3 PL 22382623 T PL22382623 T PL 22382623T PL 4299063 T3 PL4299063 T3 PL 4299063T3
- Authority
- PL
- Poland
- Prior art keywords
- bioavailability
- dissolution profile
- suitable dissolution
- oral capsules
- showing suitable
- Prior art date
Links
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 title 1
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 title 1
- 229960005370 atorvastatin Drugs 0.000 title 1
- 239000002775 capsule Substances 0.000 title 1
- 238000004090 dissolution Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22382623.1A EP4299063B1 (en) | 2022-06-30 | 2022-06-30 | Oral capsules comprising atorvastatin tablets showing suitable dissolution profile and bioavailability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4299063T3 true PL4299063T3 (pl) | 2024-06-10 |
Family
ID=82403771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22382623.1T PL4299063T3 (pl) | 2022-06-30 | 2022-06-30 | Kapsułki doustne zawierające tabletki atorwastatyny wykazujące odpowiedni profil rozpuszczania i biodostępność |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4299063B1 (pl) |
| ES (1) | ES2989428T3 (pl) |
| HR (1) | HRP20240628T1 (pl) |
| HU (1) | HUE066396T2 (pl) |
| PL (1) | PL4299063T3 (pl) |
| WO (1) | WO2024003281A1 (pl) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA99758C2 (ru) | 2008-03-28 | 2012-09-25 | Феррер Интернасиональ С.А. | Капсула для профилактики сердечно-сосудистых заболеваний |
| EP2810644A1 (en) | 2013-06-06 | 2014-12-10 | Ferrer Internacional, S.A. | Oral formulation for the treatment of cardiovascular diseases |
| EP3184103A1 (en) * | 2015-12-21 | 2017-06-28 | Hexal AG | Pharmaceutical composition comprising atorvastatin or a salt thereof |
| KR102496243B1 (ko) * | 2020-01-14 | 2023-02-07 | 일동제약(주) | 아토르바스타틴 및 에제티미브를 포함하는 정제 |
-
2022
- 2022-06-30 PL PL22382623.1T patent/PL4299063T3/pl unknown
- 2022-06-30 HU HUE22382623A patent/HUE066396T2/hu unknown
- 2022-06-30 ES ES22382623T patent/ES2989428T3/es active Active
- 2022-06-30 EP EP22382623.1A patent/EP4299063B1/en active Active
- 2022-06-30 HR HRP20240628TT patent/HRP20240628T1/hr unknown
-
2023
- 2023-06-29 WO PCT/EP2023/067877 patent/WO2024003281A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HUE066396T2 (hu) | 2024-08-28 |
| EP4299063B1 (en) | 2024-05-01 |
| WO2024003281A1 (en) | 2024-01-04 |
| EP4299063C0 (en) | 2024-05-01 |
| HRP20240628T1 (hr) | 2024-09-27 |
| ES2989428T3 (es) | 2024-11-26 |
| EP4299063A1 (en) | 2024-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2655A (en) | Capsule formulation of pirfenidone and pharmaceutically acceptable excipients | |
| DK1467712T4 (da) | Fremgangsmåde til at fremstille en tolags farmaceutisk tablet omfattende telmisartan og hydrochlorthiazid | |
| DK1534237T3 (da) | Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf | |
| CA224159S (en) | Oral dosage tablet | |
| ZA200602260B (en) | A pharmaceutical composition comprising a P2X7 receptor antagonist and a nonsteroidal anti-inflammatory drug | |
| AU2003304236A1 (en) | Pharmaceutical solid dosage forms exhibiting reproductible drug release profile | |
| AU2003260239A1 (en) | Solid dosage forms for rapid dissolution of poorly soluble drugs | |
| EP1855647A4 (en) | PHARMACEUTICAL ORAL DOSAGE FORM WITH DELAYED RELEASE AND METHOD OF MANUFACTURING THEREOF | |
| HUE066396T2 (hu) | Orális kapszulák, amelyek atorvasztatin tablettákat tartalmaznak, amelyek megfelelõ oldódási profilt és biológiai hozzáférhetõséget mutatnak | |
| IL318547A (en) | Orodispersible pharmaceutical tablet containing cariprazine | |
| ZA200704530B (en) | Formulations for production of capsule shells and capsules | |
| CA233192S (en) | Capsule for pharmaceutical products | |
| AU2003269050A1 (en) | Method for decreasing bioavailability variability of an orally administered medicine | |
| CN309452015S (en) | Pharmaceutical capsule | |
| GB202207916D0 (en) | Immediate release tablets containing poorly soluble drugs | |
| EM150346890002S (pl) | Tabletki farmaceutyczne | |
| EM150346890005S (pl) | Tabletki farmaceutyczne | |
| EM150346890011S (pl) | Tabletki farmaceutyczne | |
| EM150346890008S (pl) | Tabletki farmaceutyczne | |
| EM150346890007S (pl) | Tabletki farmaceutyczne | |
| EM150346890004S (pl) | Tabletki farmaceutyczne | |
| EM150346890001S (pl) | Tabletki farmaceutyczne | |
| EM150281390002S (pl) | Tabletki farmaceutyczne | |
| EM150281390001S (pl) | Tabletki farmaceutyczne | |
| CA199173S (en) | Pharmaceutical tablet |